DOI: https://dx.doi.org/10.18203/2394-6040.ijcmph20220266
Published: 2022-01-28

COVID-19 vaccination in India: is it in right direction?

Ankit Kumar, Mahendra Singh, Bheem Dutt Semwal

Abstract


Coronavirus disease (COVID-19), is an infectious disease caused by a newly discovered coronavirus (SARS-CoV-2), which has spread rapidly throughout the world. In March 2020, the World Health Organization (WHO) declared the COVID-19 outbreak a pandemic. The pandemic has severely ravaged health systems and economic and social progress globally. In India, 3,36,52,745 confirmed COVID-19 cases and over 4,46,918  deaths have been reported as of 25 Sep 2021. Symptoms of COVID-19 most commonly manifests as fever, dry cough, shortness of breath and tiredness. Most people (80%) experience mild disease and recover without hospitalization, while around 20% may become more seriously affected. While countries, including India, have taken strong measures to contain the spread of COVID-19 through better diagnostics and treatment, vaccines will provide a lasting solution by enhancing immunity and containing the disease spread. In response to the pandemic, the vaccine development process has been fast-tracked. COVID-19 vaccination dry run: just like army drills, dry run is a dummy process that helped the government assesses how ready we are for the COVID-19 immunization at the national level. It also highlighted any shortcomings in the mechanism laid out for the coronavirus vaccine drive so that we can address them before time and avoid any difficulty or problems during the actual immunization process. After administration of vaccine in population and recent research study has been done in India- that efficacy of Covishield vaccine is more than Covaxin vaccine. 


Keywords


Covaxin, Covieshield, Dry run, SARS-COV-2, Sputnik V

Full Text:

PDF

References


Coronavirus India latest updates: new cases stay under 30,000 for second straight day. BloombergQuint. Available at: https://www. bloombergquint.com/coronavirus-outbreak/ coronavirus-india-latest-updates-new-cases-stay-under-30000-for-second-straight-day. Accessed on 2 December 2021.

Branswell H. A side-by-side comparison of the Pfizer/BioNTech and Moderna vaccines. STAT. Available at: https://www.icpcovid.com/sites/ default/files/2020-12/Ep%2095%204%20A%20 side-by-side%20comparison%20of%20the%20 Pfizer_BioNTech%20and%20Moderna%20vaccines.pdf. Accessed on 24 December 2020.

Beaumont P. Covid-19 vaccine: who are countries prioritising for first doses?" The Guardian. Available from; https://www.theguardian.com/ world/2020/nov/18/covid-19-vaccine-who-are-countries-prioritising-for-first-doses. Accessed on 26 December2020.

Coronavirus (COVID-19) Vaccinations. Our World in Data. Available at: https://ourworldindata. org/covid-vaccinations. Accessed on 1 January 2021.

Mullard a. How COVID vaccines are being divvied up around the world Canada leads the pack in terms of doses secured per capita. Nature. Available at: https://www.nature.com/articles/d41586-020-03370-6. Accessed on 11 December 2020.

Perappadan BS. Covaxin recipients asked to sign consent form on ‘clinical trial mode’. The Hindu. New Delhi. Available at: https://www.thehindu. com/news/national/coronavirus-bharat-biotech-to-pay-compensation-if-covaxin-vaccine-causes-side-effects/article33587377.ece. Accessed on 16 January 2020.

https://pib.gov.in/PressReleseDetailm.aspx?PRID=1758073

Covovax and Corbevax: What we know about India's new Covid vaccines. BBC News. Available at: https://www.bbc.com/news/world-asia-india-55748124. Accessed on 16 January 2020.

https://twitter.com/amir35902/status/1381815733009571842

COVID vaccine immunity is waning- how much does that matter? Nature. Available at: https://www.nature.com/articles/d41586-021-02532-4. Accessed on 16 January 2020.